FIGURE

Fig. 5

ID

ZDB-FIG-240521-28

Publication

Chakraborty et al., 2024 - Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

(A) Schematic representation of VEGFR2 signaling in angiogenesis. (64,65) Signaling modules probed are highlighted (KEGG pathway database). (B–D) In the left panel is the representative Western blot showing the level of VEGFR2(B), PLC-γ (C), and ERK1/2 (D) phosphorylation after treating the HMEC-1 cells with the indicated compounds (10 μM) for 6 h followed by activation with VEGF165 (30 ng/mL). In the right panel, the bar plots represent the densitometric quantification of Y1175(B), Y783(C), or T202/Y204(D) phosphorylation level after compound treatment. The error bar is the standard deviation from three independent experiments. (E) Ca2+ flux is determined from the plot of change in fluorescence of Fluo-4 as a function of time in HMEC-1 cells treated with the indicated compounds (10 μM) for 3 h followed by activation with VEGF165 (30 ng/mL).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J. Med. Chem.